EFFECT OF GLUCOSE, INSULIN, AND HYPERTONICITY ON ATRIAL-NATRIURETIC-PEPTIDE LEVELS IN MAN

被引:29
作者
CLARK, BA
SCLATER, A
EPSTEIN, FH
ELAHI, D
机构
[1] HARVARD UNIV,BETH ISRAEL HOSP,SCH MED,DEPT MED,DIV NEPHROL,BOSTON,MA 02215
[2] HARVARD UNIV,BETH ISRAEL HOSP,SCH MED,DEPT MED,DIV GERONTOL,BOSTON,MA 02215
[3] HARVARD UNIV,CTR STUDY KIDNEY DIS,CAMBRIDGE,MA 02138
[4] BROCKTON W ROXBURY VET ADM MED CTR,CTR GERIATR RES EDUC CLIN,BOSTON,MA
来源
METABOLISM-CLINICAL AND EXPERIMENTAL | 1993年 / 42卷 / 02期
关键词
D O I
10.1016/0026-0495(93)90040-U
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
To determine the effect of hyperglycemia and hyperinsulinemia on atrial natriuretic peptide (ANP) levels in man, we studied normotensive nondiabetic volunteers (aged 25 to 63 years) during infusion of insulin and/or 20% dextrose (glucose clamp technique) to achieve three different states of "glycemia/hyperinsulinemia," as follows: (1) euglycemia for 2 hours during infusion of insulin (80 mU · m-2 · min-1), resulting in plasma insulin levels of approximately 1,200 pmol/L (n = 9); (2) moderate stable hyperglycemia at a level of 11 mmol/L (198 mg/dL) for 2 hours, with infusion of glucagon-like peptide-1 (7-37) amide (GLP-1) during the second hour, which increased endogenous insulin responses to approximately 2,100 pmol/L (n = 9); and (3) marked stable hyperglycemia at a level of 18.5 mmol/L (330 mg/dL) for 2 hours, with endogenous insulin responses of approximately 720 pmol/L (n = 9). In addition, six patients with non-insulin-dependent diabetes mellitus were studied with the GLP-1 protocol at a hyperglycemic level of 14.5 mmol/L (261 mg/dL). In normal subjects, plasma ANP levels increased significantly from 3.0 ± 0.4 to 4.6 ± 0.8 pmol/L during marked hyperglycemia, but did not change during euglycemia or moderate hyperglycemia despite higher insulin levels (P < .01, ANOVA). Sodium excretion rates were also highest during the marked hyperglycemic study (125 ± 14 v 91 ± 7 v 74 ± 10 μmol/min, P < .05, marked v moderate hyperglycemia v euglycemia). In diabetic subjects, ANP levels increased significantly from 12.5 ± 4.1 to 21.1 ± 5.0 pmol/L during hyperglycemia. To determine the contribution of hypertonicity to the increases in ANP levels, seven subjects underwent infusion of 5% saline and 0.9% saline on separate occasions to produce equivalent degrees of volume expansion. Hypertonicity was shown to contribute significantly to ANP elevation, as the increment in ANP levels was significantly greater with 5% saline than with 0.9% saline despite similar changes in plasma volume. In summary, marked hyperglycemia produced acutely can increase plasma ANP levels via a mechanism that is unrelated to hyperinsulinemia; the mechanism may be related to an increase in both plasma tonicity and volume. Hyperglycemia may contribute to the increased circulating ANP levels observed in diabetic subjects. © 1993.
引用
收藏
页码:224 / 228
页数:5
相关论文
共 20 条
[1]   BIOLOGICALLY-ACTIVE ATRIAL PEPTIDES [J].
BALLERMANN, BJ ;
BRENNER, BM .
JOURNAL OF CLINICAL INVESTIGATION, 1985, 76 (06) :2041-2048
[2]   FUNCTIONAL IMPLICATIONS OF DECREASED RENAL CORTICAL ATRIAL-NATRIURETIC-PEPTIDE BINDING IN EXPERIMENTAL DIABETES [J].
BENIGNI, A ;
PERICO, N ;
DADAN, J ;
GABANELLI, M ;
GALBUSERA, M ;
BOCCARDO, P ;
MENNINI, T ;
REMUZZI, G .
CIRCULATION RESEARCH, 1990, 66 (06) :1453-1460
[3]   REGULATION OF SPLANCHNIC AND PERIPHERAL GLUCOSE-UPTAKE BY INSULIN AND HYPERGLYCEMIA IN MAN [J].
DEFRONZO, RA ;
FERRANNINI, E ;
HENDLER, R ;
FELIG, P ;
WAHREN, J .
DIABETES, 1983, 32 (01) :35-45
[4]   ESCAPE OF HEPATIC GLUCOSE-PRODUCTION DURING HYPERGLYCEMIC CLAMP [J].
ELAHI, D ;
MENEILLY, GS ;
MINAKER, KL ;
ANDERSEN, DK ;
ROWE, JW .
AMERICAN JOURNAL OF PHYSIOLOGY, 1989, 257 (05) :E704-E711
[5]   NONCALCIUM-DEPENDENT MODULATION OF INVITRO ATRIAL-NATRIURETIC-FACTOR RELEASE BY EXTRACELLULAR OSMOLALITY [J].
GIBBS, DM .
ENDOCRINOLOGY, 1987, 120 (01) :194-197
[6]  
GOETZ K, 1986, AM J PHYSIOL, V254, pE1
[7]   RELATIONSHIP BETWEEN ATRIAL GRANULARITY AND RELEASE OF ATRIAL NATRIURETIC FACTOR IN RATS WITH DIABETES-MELLITUS [J].
HEBDEN, RA ;
TODD, ME ;
MCNEILL, JH .
AMERICAN JOURNAL OF PHYSIOLOGY, 1989, 257 (04) :R932-R938
[8]   EFFECTS OF PLASMA-VOLUME AND OSMOLALITY ON SECRETION OF ATRIAL NATRIURETIC PEPTIDE AND VASOPRESSIN IN MAN [J].
KAMOI, K ;
SATO, F ;
ARAI, O ;
ISHIBASHI, M ;
YAMAJI, T .
ACTA ENDOCRINOLOGICA, 1988, 118 (01) :51-58
[9]  
NAKAMURA T, 1990, JPN HEART J, V31, P671
[10]   INSULINOTROPIC ACTION OF GLUCAGON-LIKE PEPTIDE-I-(7-37) IN DIABETIC AND NONDIABETIC SUBJECTS [J].
NATHAN, DM ;
SCHREIBER, E ;
FOGEL, H ;
MOJSOV, S ;
HABENER, JF .
DIABETES CARE, 1992, 15 (02) :270-276